Copyright Reports & Markets. All rights reserved.

Global Soliris Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Soliris Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Soliris Drug Market Size Growth Rate by Product
      • 1.4.2 Plasma Exchange
      • 1.4.3 Plasma Infusion
    • 1.5 Market by End User
      • 1.5.1 Global Soliris Drug Market Size Growth Rate by End User
      • 1.5.2 PNH
      • 1.5.3 aHUS
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Soliris Drug Market Size
      • 2.1.1 Global Soliris Drug Revenue 2014-2025
      • 2.1.2 Global Soliris Drug Sales 2014-2025
    • 2.2 Soliris Drug Growth Rate by Regions
      • 2.2.1 Global Soliris Drug Sales by Regions
      • 2.2.2 Global Soliris Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Soliris Drug Sales by Manufacturers
      • 3.1.1 Soliris Drug Sales by Manufacturers
      • 3.1.2 Soliris Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Soliris Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Soliris Drug Revenue by Manufacturers
      • 3.2.1 Soliris Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Soliris Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Soliris Drug Price by Manufacturers
    • 3.4 Soliris Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Soliris Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Soliris Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Soliris Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Soliris Drug Sales by Product
    • 4.2 Global Soliris Drug Revenue by Product
    • 4.3 Soliris Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Soliris Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Soliris Drug by Countries
      • 6.1.1 North America Soliris Drug Sales by Countries
      • 6.1.2 North America Soliris Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Soliris Drug by Product
    • 6.3 North America Soliris Drug by End User

    7 Europe

    • 7.1 Europe Soliris Drug by Countries
      • 7.1.1 Europe Soliris Drug Sales by Countries
      • 7.1.2 Europe Soliris Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Soliris Drug by Product
    • 7.3 Europe Soliris Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Soliris Drug by Countries
      • 8.1.1 Asia Pacific Soliris Drug Sales by Countries
      • 8.1.2 Asia Pacific Soliris Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Soliris Drug by Product
    • 8.3 Asia Pacific Soliris Drug by End User

    9 Central & South America

    • 9.1 Central & South America Soliris Drug by Countries
      • 9.1.1 Central & South America Soliris Drug Sales by Countries
      • 9.1.2 Central & South America Soliris Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Soliris Drug by Product
    • 9.3 Central & South America Soliris Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Soliris Drug by Countries
      • 10.1.1 Middle East and Africa Soliris Drug Sales by Countries
      • 10.1.2 Middle East and Africa Soliris Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Soliris Drug by Product
    • 10.3 Middle East and Africa Soliris Drug by End User

    11 Company Profiles

    • 11.1 Alexion
      • 11.1.1 Alexion Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alexion Soliris Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alexion Soliris Drug Products Offered
      • 11.1.5 Alexion Recent Development

    12 Future Forecast

    • 12.1 Soliris Drug Market Forecast by Regions
      • 12.1.1 Global Soliris Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Soliris Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Soliris Drug Market Forecast by Product
      • 12.2.1 Global Soliris Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Soliris Drug Revenue Forecast by Product 2019-2025
    • 12.3 Soliris Drug Market Forecast by End User
    • 12.4 North America Soliris Drug Forecast
    • 12.5 Europe Soliris Drug Forecast
    • 12.6 Asia Pacific Soliris Drug Forecast
    • 12.7 Central & South America Soliris Drug Forecast
    • 12.8 Middle East and Africa Soliris Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Soliris Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
      The global Soliris Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Soliris Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Soliris Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Soliris Drug in these regions.
      This research report categorizes the global Soliris Drug market by top players/brands, region, type and end user. This report also studies the global Soliris Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Alexion

      Market size by Product
      Plasma Exchange
      Plasma Infusion
      Market size by End User
      PNH
      aHUS
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Soliris Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Soliris Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Soliris Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Soliris Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Soliris Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Soliris Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now